possible link between atypical antipsychotics and diabetes
You'll see more attention focused on the possible link between atypical antipsychotics and diabetes.
FDA and drug companies will battle out new labeling requirements for warnings about diabetes risks in patients taking atypicals.
The FDA wants the warnings to apply to ALL atypicals. But some companies don't think their drug needs the new warning at all.